BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9797415)

  • 1. Overview of the clinical features of cefixime.
    Adam D
    Chemotherapy; 1998 Sep; 44 Suppl 1():1-5. PubMed ID: 9797415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefixime in the treatment of upper respiratory tract infections and otitis media.
    de Lalla F
    Chemotherapy; 1998 Sep; 44 Suppl 1():19-23. PubMed ID: 9797419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical role of cefixime in community-acquired infections.
    Chemotherapy; 1998 Sep; 44 Suppl 1():35-8. PubMed ID: 9797423
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessment of the use of cefixime for switch therapy.
    Low DE
    Infection; 1995; 23 Suppl 2():S91-4. PubMed ID: 8537140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cefixime, the first oral third-generation cephalosporin].
    Roche G
    Presse Med; 1989 Oct; 18(32):1541-4. PubMed ID: 2530527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of cefprozil, cefpodoxime proxetil, loracarbef, cefixime, and ceftibuten.
    Schatz BS; Karavokiros KT; Taeubel MA; Itokazu GS
    Ann Pharmacother; 1996 Mar; 30(3):258-68. PubMed ID: 8833562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefixime. A review of its antibacterial activity. Pharmacokinetic properties and therapeutic potential.
    Brogden RN; Campoli-Richards DM
    Drugs; 1989 Oct; 38(4):524-50. PubMed ID: 2684593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiologic and clinical aspects of a trial of once daily cefixime compared with twice daily cefaclor for treatment of acute otitis media in infants and children.
    Harrison CJ; Chartrand SA; Pichichero ME
    Pediatr Infect Dis J; 1993 Jan; 12(1):62-9. PubMed ID: 8417428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the activity of cefixime and activities of other oral antibiotics against adult clinical isolates of Moraxella (Branhamella) catarrhalis containing BRO-1 and BRO-2 and Haemophilus influenzae.
    Nash DR; Flanagan C; Steele LC; Wallace RJ
    Antimicrob Agents Chemother; 1991 Jan; 35(1):192-4. PubMed ID: 1901696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of clarithromycin compared to cefixime as outpatient treatment of lower respiratory tract infections.
    Neu HC; Chick TW
    Chest; 1993 Nov; 104(5):1393-9. PubMed ID: 8222794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination cefixime/amoxicillin against penicillin-resistant Streptococcus pneumoniae infection.
    Matsumoto Y
    Chemotherapy; 1998 Sep; 44 Suppl 1():6-9. PubMed ID: 9797416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind comparison of cefixime and cefaclor in the treatment of acute otitis media in children.
    Piippo T; Stefansson S; Pitkäjärvi T; Lundberg C
    Scand J Infect Dis; 1991; 23(4):459-65. PubMed ID: 1957129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefixime. A review of its therapeutic efficacy in lower respiratory tract infections.
    Markham A; Brogden RN
    Drugs; 1995 Jun; 49(6):1007-22. PubMed ID: 7641600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vitro activity of cefixime, cefaclor and loracarbef against urinary pathogens.
    Hamilton-Miller JM; Brumfitt W
    Drugs Exp Clin Res; 1991; 17(10-11):517-9. PubMed ID: 1841042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter surveillance of antimicrobial resistance of Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 14 oral antibiotics.
    Hsueh PR; Huang WK; Shyr JM; Lau YJ; Liu YC; Luh KT
    J Formos Med Assoc; 2004 Sep; 103(9):664-70. PubMed ID: 15361938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of cefixime in the treatment of otitis media in infants and children.
    Bluestone CD
    Pediatr Infect Dis J; 1993 Jan; 12(1):75-82. PubMed ID: 8417430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefixime in the treatment of patients with lower respiratory tract infections: results of US clinical trials.
    Quintiliani R
    Clin Ther; 1996; 18(3):373-90; discussion 372. PubMed ID: 8829015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefixime for switch therapy.
    Hamilton-Miller J
    Chemotherapy; 1998 Sep; 44 Suppl 1():24-7. PubMed ID: 9797420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefixime in the treatment of respiratory and urinary tract infections.
    Ludwig E
    Chemotherapy; 1998 Sep; 44 Suppl 1():31-4. PubMed ID: 9797422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefixime.
    Leggett NJ; Caravaggio C; Rybak MJ
    DICP; 1990 May; 24(5):489-95. PubMed ID: 2188437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.